Zealand Pharma A/S | ZEAL - Selling And Administration Expenses


Zealand Pharma A/S reported 91.81M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 447K 138K Mar/2026
Avita Medical AUD 19.03M 1.95M Dec/2025
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
Moderna USD 216M 43M Jun/2026
Organon & Co USD 424M 9M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Tectonic Therapeutic USD 6.43M 2.99M Mar/2026
Tilray USD 24.85M 1.7M Sep/2025
Viatris USD 928.8M 101.9M Mar/2026
Xeris Pharmaceuticals USD 53.14M 10.51M Mar/2026
Zealand Pharma A/S 91.81M 99.04M Dec/2025